Company: ANTX
Filing Date: 2025-03-25
Form Type: 10-K
Source: 0000950170-25-044366
Chunk: 37

Company: AN2 Therapeutics, Inc.
Filing Date: 2025-03-25
Form: 10-K
Item: Item 15
Chunk 37
---
(a)The following documents are filed as a part of this Annual Report:

(1)Financial Statements:

    Report of Independent Registered Public Accounting Firm (PCAOB ID: 238)
    F-2

    Balance Sheets as of December 31, 2024 and 2023
    F-3

    Statements of Operations and Comprehensive Loss for the years ended December 31, 2024 and 2023
    F-4

    Statements of Stockholders’ Equity for the years ended December 31, 2024 and 2023
    F-5

    Statements of Cash Flows for the years ended December 31, 2024 and 2023
    F-6

    Notes to the Financial Statements
    F-7

(2)Financial Statement Schedules:

All financial statement schedules have been omitted because they are not applicable, not required or the information required is shown in the financial statements or the notes thereto.

(3)Exhibits:

The list of exhibits filed with this Annual Report on Form 10-K is set forth in the Exhibit Index preceding the signature page and is incorporated herein by reference or filed with this Annual Report, in each case as indicated therein (numbered in accordance with Item 601 of Regulation S-K).